A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D

B. L. Riggs, John Christopher G. Gallagher, H. F. DeLuca, A. J. Edis, P. W. Lambert, C. D. Arnaud

Research output: Contribution to journalArticle

28 Scopus citations


Although most patients with postmenopausal osteoporosis have normal or low values for serum immunoreactive parathyroid hormone (iPTH), the authors have reported previously that a small subset (about 10% of the total group) have increased values. The authors studied three patients representative of this latter group. Serum iPTH was two to three times higher than the age-adjusted normal mean, serum ionized calcium and total calcium were in the lower half of the normal range, and serum 1,25-dihydroxyvitamin D [1,25(OH) 2D] was in the low-normal range. Six months of treatment of one patients with 0.5 μg/day of synthetic 1,25(OH) 2D improved calcium absorption and balance; however, serum iPTH remained high. After surgical removal of 1,010 mg of hyperplastic parathyroid tissue, serum iPTH decreased to normal. These and other data suggest that increased serum iPTH in these patients was caused by secondary hyperparathyroidism, possibly because of inadequate conversion of 25-OH-D to 1,25(OH) 2D.

Original languageEnglish
Pages (from-to)701-706
Number of pages6
JournalMayo Clinic Proceedings
Issue number11
StatePublished - 1978
Externally publishedYes


All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this